Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6

Immunology Letters

Volumn 160, Issue 1, 2014, Pages 1-10

  Dehai, Che ^a   Bo, Pan ^a   Qiang, Tian ^a   Lihua, Shang ^a   Fang, Liu ^a   Shi, Jin ^a   Jingyan, Cao ^a   Yan, Yu ^a   Guangbin, Wang ^a   Zhenjun, Yuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

A549 and H1299 cells; Co culture; EMT; IL 6; Invasion; THP 1 derived macrophages

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ARTICLE; CANCER CELL; CANCER MORTALITY; CAUSE OF DEATH; CELL CONTACT; CELL INVASION; COCULTURE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; BIOSYNTHESIS; DRUG EFFECTS; IMMUNOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MACROPHAGES; NEOPLASM INVASIVENESS; PHENOTYPE;

EID: 84922273516     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.03.004     Document Type: Article

References (38)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2012, 62:10-29.
2. Angulo M., Lecuona E., Sznajder J.I. Role of MicroRNAs in lung disease. Arch Bronconeumol 2012, 48:325-330.
3. Gao D., Vahdat L.T., Wong S., Chang J.C., Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 2012, 72:4883-4889.
4. Nagathihalli N.S., Merchant N.B. Src-mediated regulation of E-cadherin and EMT in pancreatic cancer. Front Biosci 2012, 17:2059-2069.
5. Bremnes R.M., Veve R., Gabrielson E., Hirsch F.R., Baron A., Bemis L., et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small cell lung cancer. J Clin Oncol 2002, 20:2417-2428.
6. Mizutani H., Okano T., Minegishi Y., Matsuda K., Sudoh J., Kitamura K., et al. HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner. Oncol Lett 2010, 1:1011-1016.
7. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
8. Chen J.J., Lin Y.C., Yao P.L., Yuan A., Chen H.Y., Shun C.T., et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005, 23:953-964.
9. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
10. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
11. Yadav A., Kumar B., Datta J., Teknos T.N., Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 2011, 9:1658-1667.
12. Fernando R.I., Castillo M.D., Litzinger M., Hamilton D.H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res 2011, 71:5296-5306.
13. Guo Y., Xu F., Lu T., Duan Z., Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 2012, 38:904-910.
14. Schafer Z.T., Brugge J.S. IL-6 involvement in epithelial cancers. J Clin Invest 2007, 117:3660-3663.
15. Gao S.P., Mark K.G., Leslie K., Pao W., Motoi N., Gerald W.L., et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 2007, 117:3846-3856.
16. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. J Exp 1991, 47:22-31.
17. Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 2001, 11:97-104.
18. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature 2001, 411:375-379.
19. Bhowmick N.A., Moses H.L. Tumor-stroma interactions. Curr Opin Genet Dev 2005, 15:97-101.
20. Mantovani A. Cancer: inflammation by remote control. Nature 2005, 435:752-753.
21. Chen J.J., Yao P.L., Yuan A., Hong T.M., Shun C.T., Kuo M.L., et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003, 9:729-737.
22. Hong T.M., Teng L.J., Shun C.T., Peng M.C., Tsai J.C. Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J Neurooncol 2009, 93:289-301.
23. Hagemann T., Robinson S.C., Schulz M., Trumper L., Balkwill F.R., Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25:1543-1549.
24. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
25. You Z., Shi X.B., DuRaine G., Haudenschild D., Tepper C.G., Lo S.H., et al. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res 2006, 66:175-183.
26. Ryder M., Ghossein R.A., Ricarte-Filho J.C., Knauf J.A., Fagin J.A. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 2008, 15:1069-1074.
27. Lee C.H., Espinosa I., Vrijaldenhoven S., Subramanian S., Montgomery K.D., Zhu S., et al. Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 2008, 14:1423-1430.
28. Shieh Y.S., Hung Y.J., Hsieh C.B., Chen J.S., Chou K.C., Liu S.Y. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands. Ann Surg Oncol 2009, 16:751-760.
29. Zhang B.C., Gao J., Wang J., Rao Z.G., Wang B.C., Gao J.F. Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adneocarcinoma. Med Oncol 2011, 28:1447-1452.
30. Wang R., Zhang J., Chen S., Lu M., Luo X., Yao S., et al. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cell cancer invasion and progression. Lung Cancer 2011, 74:188-196.
31. Cortez-Retamozo V., Engblom C., Pittet M.J. Remote control of macrophage production by cancer. Oncoimmumology 2013, 2:e24183.
32. Quatromoni J.G., Eruslanov E. Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res 2012, 4:376-389.
33. Anton K., Glod J. Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 2009, 10:185-191.
34. Angst E., Reber H.A., Hines O.J., Eibl G. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery 2008, 144:57-65.
35. Guadamillas M.C., Cerezo A., Del Pozo M.A. Overcoming anoikis-pathways to anchorage-independent growth in cancer. J Cell Sci 2011, 124:3189-3197.
36. Ko H., Kim S., Jin C.H., Lee E., Ham S., Yook J.I., et al. Protein kinase casein kinase 2-mediated upregulation of N-cadherin confers anoikis resistance on esophageal carcinoma cells. Mol Cancer Res 2012, 10:1032-1038.
37. Liu C.Y., Xu J.Y., Shi X.Y., Huang W., Ruan T.Y., Xie P., et al. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest 2013, 93:844-854.
38. Sullivan N.J., Sasser A.K., Axel A.E., Vesuna F., Raman V., Ramirez N., et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009, 28:2940-2947.